Publication | Open Access
Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
138
Citations
18
References
2014
Year
Trastuzumab in combination with SP showed promising antitumour activity and manageable toxic effects in patients with HER2-positive AGC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1